Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in DenmarkElisabeth Framke, Melinda Magyari, Finn Sellebjerg et al.|Multiple Sclerosis Journal|2024Cited by 10